Yixintang Pharmaceutical Group's commendable performance is attributed to high return reinvestment, markedly increasing earnings. With predicted future robust ROE of 15% and growth rate, the company's successful investment strategy suggests a bright future.
一心堂股票讨论区
暂无评论